These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24102962)

  • 41. Social touch modulates endogenous μ-opioid system activity in humans.
    Nummenmaa L; Tuominen L; Dunbar R; Hirvonen J; Manninen S; Arponen E; Machin A; Hari R; Jääskeläinen IP; Sams M
    Neuroimage; 2016 Sep; 138():242-247. PubMed ID: 27238727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social Laughter Triggers Endogenous Opioid Release in Humans.
    Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L
    J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography.
    Saji H; Tsutsumi D; Magata Y; Iida Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1992 Feb; 6(1):63-7. PubMed ID: 1325823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.
    Nummenmaa L; Manninen S; Tuominen L; Hirvonen J; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Dunbar RI; Sams M
    Hum Brain Mapp; 2015 Sep; 36(9):3621-8. PubMed ID: 26046928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.
    Zubieta JK; Bueller JA; Jackson LR; Scott DJ; Xu Y; Koeppe RA; Nichols TE; Stohler CS
    J Neurosci; 2005 Aug; 25(34):7754-62. PubMed ID: 16120776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino ML; Dannals RF; Frost JJ
    Psychopharmacology (Berl); 2008 Nov; 200(4):475-86. PubMed ID: 18762918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones.
    Smith YR; Zubieta JK; del Carmen MG; Dannals RF; Ravert HT; Zacur HA; Frost JJ
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4498-505. PubMed ID: 9851799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.
    Zubieta JK; Gorelick DA; Stauffer R; Ravert HT; Dannals RF; Frost JJ
    Nat Med; 1996 Nov; 2(11):1225-9. PubMed ID: 8898749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered central micro-opioid receptor binding after psychological trauma.
    Liberzon I; Taylor SF; Phan KL; Britton JC; Fig LM; Bueller JA; Koeppe RA; Zubieta JK
    Biol Psychiatry; 2007 May; 61(9):1030-8. PubMed ID: 16945349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.
    Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety.
    Nummenmaa L; Karjalainen T; Isojärvi J; Kantonen T; Tuisku J; Kaasinen V; Joutsa J; Nuutila P; Kalliokoski K; Hirvonen J; Hietala J; Rinne J
    Neuropsychopharmacology; 2020 Oct; 45(11):1953-1959. PubMed ID: 32473595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
    Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
    Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.
    Mick I; Myers J; Stokes PR; Erritzoe D; Colasanti A; Bowden-Jones H; Clark L; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Nutt DJ; Lingford-Hughes AR
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2069-74. PubMed ID: 24807268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
    Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
    Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations in endogenous opioid functional measures in chronic back pain.
    Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK
    J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography.
    Mayberg HS; Sadzot B; Meltzer CC; Fisher RS; Lesser RP; Dannals RF; Lever JR; Wilson AA; Ravert HT; Wagner HN
    Ann Neurol; 1991 Jul; 30(1):3-11. PubMed ID: 1656846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.